These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
343 related articles for article (PubMed ID: 31808136)
21. Oral Anticoagulation and Adverse Outcomes after Ischemic Stroke in Heart Failure Patients without Atrial Fibrillation. Saeed O; Zhang S; Patel SR; Jorde UP; Garcia MJ; Bulcha N; Gupta T; Xian Y; Matsouaka R; Shah S; Smith EE; Schwamm LH; Fonarow GC J Card Fail; 2021 Aug; 27(8):857-864. PubMed ID: 33975786 [TBL] [Abstract][Full Text] [Related]
22. Comparative Stroke, Bleeding, and Mortality Risks in Older Medicare Patients Treated with Oral Anticoagulants for Nonvalvular Atrial Fibrillation. Graham DJ; Baro E; Zhang R; Liao J; Wernecke M; Reichman ME; Hu M; Illoh O; Wei Y; Goulding MR; Chillarige Y; Southworth MR; MaCurdy TE; Kelman JA Am J Med; 2019 May; 132(5):596-604.e11. PubMed ID: 30639551 [TBL] [Abstract][Full Text] [Related]
23. To treat or not to treat: a comparative effectiveness analysis of oral anticoagulant outcomes among U.S. nursing home residents with atrial fibrillation. Chen Q; Baek J; Goldberg R; Tjia J; Lapane K; Alcusky M BMC Geriatr; 2024 Jul; 24(1):619. PubMed ID: 39030486 [TBL] [Abstract][Full Text] [Related]
24. Predictors of intracranial hemorrhage in patients with atrial fibrillation treated with oral anticoagulants: Insights from the GARFIELD-AF and ORBIT-AF registries. Lim TW; Camm AJ; Virdone S; Singer DE; Bassand JP; Fonarow GC; Fox KAA; Ezekowitz M; Gersh BJ; Kayani G; Hylek EM; Kakkar AK; Mahaffey KW; Pieper KS; Peterson ED; Piccini JP; Clin Cardiol; 2023 Nov; 46(11):1398-1407. PubMed ID: 37596725 [TBL] [Abstract][Full Text] [Related]
25. Post-Intracranial Hemorrhage Antithrombotic Therapy in Patients With Atrial Fibrillation. Lin SY; Chang YC; Lin FJ; Tang SC; Dong YH; Wang CC J Am Heart Assoc; 2022 Mar; 11(6):e022849. PubMed ID: 35243876 [TBL] [Abstract][Full Text] [Related]
26. Age-Dependent Anticoagulant Therapy for Atrial Fibrillation Patients with Intermediate Risk of Ischemic Stroke: A Nationwide Population-Based Study. Choi SY; Kim MH; Lee KM; Cho YR; Park JS; Yun SC; Lip GYH Thromb Haemost; 2021 Sep; 121(9):1151-1160. PubMed ID: 33307565 [TBL] [Abstract][Full Text] [Related]
27. Stroke and bleeding with non-vitamin K antagonist oral anticoagulant or warfarin treatment in patients with non-valvular atrial fibrillation: a population-based cohort study. Forslund T; Wettermark B; Andersen M; Hjemdahl P Europace; 2018 Mar; 20(3):420-428. PubMed ID: 28177459 [TBL] [Abstract][Full Text] [Related]
28. Novel Oral Anticoagulants for Primary Stroke Prevention in Hypertrophic Cardiomyopathy Patients With Atrial Fibrillation. Lee HJ; Kim HK; Jung JH; Han KD; Lee H; Park JB; Kim HM; Kim YJ; Ommen SR Stroke; 2019 Sep; 50(9):2582-2586. PubMed ID: 31340730 [TBL] [Abstract][Full Text] [Related]
29. Sex Differences in Oral Anticoagulation and Outcomes of Stroke and Intracranial Bleeding in Newly Diagnosed Atrial Fibrillation. Yong CM; Tremmel JA; Lansberg MG; Fan J; Askari M; Turakhia MP J Am Heart Assoc; 2020 May; 9(10):e015689. PubMed ID: 32394763 [TBL] [Abstract][Full Text] [Related]
30. Effectiveness and Safety of Anticoagulation Therapy in Frail Patients With Atrial Fibrillation. Kim D; Yang PS; Sung JH; Jang E; Yu HT; Kim TH; Uhm JS; Kim JY; Pak HN; Lee MH; Lip GYH; Joung B Stroke; 2022 Jun; 53(6):1873-1882. PubMed ID: 35109686 [TBL] [Abstract][Full Text] [Related]
31. Sex-Based Differences in Outcomes of Oral Anticoagulation in Patients With Atrial Fibrillation. Law SWY; Lau WCY; Wong ICK; Lip GYH; Mok MT; Siu CW; Chan EW J Am Coll Cardiol; 2018 Jul; 72(3):271-282. PubMed ID: 30012320 [TBL] [Abstract][Full Text] [Related]
32. Appropriate doses of non-vitamin K antagonist oral anticoagulants in high-risk subgroups with atrial fibrillation: Systematic review and meta-analysis. Kim IS; Kim HJ; Kim TH; Uhm JS; Joung B; Lee MH; Pak HN J Cardiol; 2018 Oct; 72(4):284-291. PubMed ID: 29706404 [TBL] [Abstract][Full Text] [Related]
33. Race/Ethnicity and Sex-Related Differences in Direct Oral Anticoagulant Initiation in Newly Diagnosed Atrial Fibrillation: A Retrospective Study of Medicare Data. Essien UR; Magnani JW; Chen N; Gellad WF; Fine MJ; Hernandez I J Natl Med Assoc; 2020 Feb; 112(1):103-108. PubMed ID: 32035755 [TBL] [Abstract][Full Text] [Related]
34. Anticoagulation medication in nontraumatic intracranial hemorrhage survivors with atrial fibrillation. Wang X; Wen D; Chen Y; You C; Ma L J Thromb Thrombolysis; 2023 Jul; 56(1):1-11. PubMed ID: 37022508 [TBL] [Abstract][Full Text] [Related]
35. Influence of gender on the clinical outcomes of Asian non-valvular atrial fibrillation patients: insights from the prospective multicentre COOL-AF registry. Krittayaphong R; Phrommintikul A; Winijkul A; Methavigul K; Komoltri C; Kaewkumdee P; Yindeengam A; BMJ Open; 2021 May; 11(5):e043862. PubMed ID: 33958338 [TBL] [Abstract][Full Text] [Related]
36. Effect of Anticoagulation on Hospitalization Costs After Intracranial Hemorrhage in Atrial Fibrillation: A Registry Study. Vestergaard AS; Skjøth F; Lip GY; Larsen TB Stroke; 2016 Apr; 47(4):979-85. PubMed ID: 26883499 [TBL] [Abstract][Full Text] [Related]
37. Should oral anticoagulants be restarted after warfarin-associated cerebral haemorrhage in patients with atrial fibrillation? Paciaroni M; Agnelli G Thromb Haemost; 2014 Jan; 111(1):14-8. PubMed ID: 24258528 [TBL] [Abstract][Full Text] [Related]
38. Timing to start anticoagulants after acute ischemic stroke with non-valvular atrial fibrillation. Al Bakr AI; AlOmar RS; Nada MAF; Ishaque N; Aljaafari D; Hadhiah K; Al Khmais FA; Zafar A; Shahid R; Shariff EM; Al Majed AM; Ahabib HK; Alabdali M J Neurol Sci; 2020 Feb; 409():116582. PubMed ID: 31812847 [TBL] [Abstract][Full Text] [Related]
39. Increased Incident Ischemic Stroke Risk in Advanced Kidney Disease: A Large-Scale Real-World Data Study. Maeda T; Nishi T; Funakoshi S; Tada K; Tsuji M; Satoh A; Kawazoe M; Yoshimura C; Arima H Am J Nephrol; 2020; 51(8):659-668. PubMed ID: 32726780 [TBL] [Abstract][Full Text] [Related]
40. Timing of oral anticoagulation in atrial fibrillation patients after acute ischaemic stroke and outcome after 3 months: results of the multicentre Berlin Atrial Fibrillation Registry. Olma MC; Tütüncü S; Hansen K; Grittner U; Kunze C; Dietzel J; Schurig J; Dimitrijeski B; Hagemann G; Hamilton F; Honermann M; Jungehuelsing GJ; Kauert A; Koennecke HC; Mackert BM; Nabavi DG; Schmehl I; Sparenberg P; Stingele R; Voelzke E; Waldschmidt C; Zeise-Wehry D; Heuschmann PU; Endres M; Haeusler KG Open Heart; 2024 Sep; 11(2):. PubMed ID: 39299734 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]